Pulmonary embolism and screening for concomitant proximal deep vein thrombosis in noncritically ill hospitalized patients with coronavirus disease 2019

Pulmonary embolism and screening for concomitant proximal deep vein thrombosis in noncritically ill hospitalized patients with coronavirus disease 2019

Álvaro Dubois-Silva, Cristina Barbagelata-López, Álvaro Mena, Patricia Piñeiro-Parga, Diego Llinares-García, Santiago Freire-Castro

Introduction

Dear Editor,

Coagulation abnormalities with elevated D-dimer levels have been identified as predictors of poor prognosis in patients with coronavirus disease 2019 (COVID-19) in China. The correlation between D-dimer levels and diagnosis and prognosis of venous thromboembolism (VTE) has been widely described. Thus, many questions regarding the relationship between these entities are emerging.
Recently, a VTE prevalence of 25% has been reported in patients with severe novel coronavirus pneumonia. However, there is limited information about the clinical characteristics of noncritically ill hospitalized patients with COVID-19 who develop pulmonary embolism (PE), or their prevalence of lower limb concomitant deep-vein thrombosis (DVT). Therefore, the purpose of this study was to analyze the clinical data and assess the prevalence of concomitant proximal DVT in COVID-19 nonintensive care unit (non-ICU) patients with PE.

Keywords: Coronavirus disease 2019, Pulmonary embolism, Deep vein thrombosis, Screening, Coagulopathy

Fonte:
Internal and Emergency Medicine (2020) 15:865–870
DOI: https://doi.org/10.1007/s11739-020-02416-x
© Società Italiana di Medicina Interna (SIMI) 2020